Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2012-12-12
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild CHEST DISCOMFORT — outcome: RECOVERED/RESOLVED; onset 2012-12-15 (study day 4.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2012-12-13 (study day 2.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate VOMITING — outcome: RECOVERED/RESOLVED; onset 2012-12-13 (study day 2.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate WEIGHT DECREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 1.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate WEIGHT DECREASED — outcome: RECOVERED/RESOLVED; onset 2012-12-12 (study day 1.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.